Investing.com - Amgen (NASDAQ:AMGN) reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Amgen announced earnings per share of $3.64 on revenue of $6.20B. Analysts polled by Investing.com anticipated EPS of $3.4 on revenue of $6.02B. That with comparison to EPS of $3.42 on revenue of $6.23B in the same period a year before. Amgen had reported EPS of $3.66 on revenue of $5.74B in the previous quarter. Analysts are expecting EPS of $3.88 and revenue of $6.06B in the upcoming quarter.
Amgen shares are down 6.21% from the beginning of the year and are trading at $225.00 , still down 7.71% from its 52 week high of $244.99 set on December 17, 2019. They are under-performing the Nasdaq 100 which is up 3.79% year to date.
Amgen shares lost 0.49% in after-hours trade after the report.
Amgen follows other major Healthcare sector earnings this month
Amgen's report follows an earnings beat by J&J on January 22, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.
Novartis ADR had beat expectations on Wednesday with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar